BTIG Reiterates Buy on Omada Health, Maintains $35 Price Target
BTIG analyst David Larsen reiterates Omada Health (NASDAQ:OMDA) with a Buy and maintains $35 price target.
Share
Why It Matters
A big investment expert says Omada Health is a good company to own and thinks its stock could be worth $35. When experts keep saying the same positive thing over time, it shows they still believe in the company's plan.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.